ZInvestorHunting

Matthew Hellauer

Solo GP · Baltimore, Maryland

Verified Active Check-WriterUS Angel

Named as the only individual (Manager of the General Partner of the Issuer) on the Form D for PTX Capital Fund III LP, a venture fund (Jun 2026) (2 vehicles on file). Also a non-executive director at 1 startup that filed Form D.

Investor IntelligenceVerified Activity

Angel Investment Confidence Score

Algorithmic score indicating recent deal velocity, check size reliability, and investment conviction in early-stage startups.

87/ 100
High Conviction Angel1 deals in last 12 months
Deal Velocity1 deals in last 12 monthsUSA & Europe pipeline
Typical CheckDisclosed on filePre-Seed / Seed
Primary FocusHealthcare, Biotech & PharmaSeries A
Direct AccessWarm Intro Recommended1-click pitch match

Why Matthew Hellauer holds a 87/100 confidence score

  • Verified active check-writing activity within the last 12 months
  • Active co-investor alongside leading venture syndicates
  • Clear domain thesis in Healthcare, Biotech & Pharma
  • Named as the only individual (Manager of the General Partner of the Issuer) on the Form D for PTX Capital Fund III LP, a venture fund (Jun 2026) (2 vehicles on file). Also a non-executive director at 1 startup that filed Form D.

Building in Healthcare, Biotech & Pharma? See how well your pitch deck matches Matthew Hellauer’s thesis.

Check My Startup Fit

Verified investment track record

Named as the only individual (Manager of the General Partner of the Issuer) on the Form D for PTX Capital Fund III LP, a venture fund (Jun 2026) (2 vehicles on file). Also a non-executive director at 1 startup that filed Form D.

Source: SEC Form D: PTX Capital Fund III LP (Jun 29, 2026) · 2 more sources

Stages
Series A
Typical check (est.)
Disclosed on file
Verified deals
3 on file
Latest activity
Jun 2026
Pitch Readiness

Is Matthew Hellauer a fit for you?

See your AI startup fit score, verified contact channels, and warm paths through your network.

What sectors does Matthew Hellauer back?

HealthcareBiotech & Pharma

Verified investments & deal activity

3 deals tracked

Recent startup investments, syndicate rounds, and public co-investments across the US and Europe.

  • PTX Capital Fund III LP

    Invested through a fund

    Jun 2026
  • Infinity Bio

    Board seat on the company's SEC filing · MD

    Jun 2023
  • PTX Infinity LLC

    Invested through a fund

    Jun 2023

Public Verification Sources

Data refreshed from SEC filings and public European announcements Oct 15, 2026. Is this you? Correct or remove this profile.

Syndicate IntelligenceUSA & Europe

Active Angels Similar to Matthew Hellauer

Founders raising in health and bio also reach out to these verified check-writers with similar portfolio focus and check sizes.

View all matching angels
Golden Seeds

Angel group · Scottsdale, AZ

97/100
$125K–$350KActive Oct 2026
HealthcareBiotech & PharmaConsumer+2
John Parker

Solo GP · Sudbury, MA

86/100
$200K–$600KActive Nov 2025
HealthcareBiotech & Pharma
Patrick Gallagher

Syndicate lead · Austin, TX

90/100
$165K–$2.25MActive Aug 2026
Biotech & PharmaHealthcare
Adam E. Fine

Solo GP · New York, NY

83/100
$1.5M–$4.5MActive Nov 2025
HealthcareBiotech & Pharma
Gaingels

Angel group · Burlington, VT

99/100
$50K–$150KActive Sep 2026
ConsumerB2B SoftwareAI & ML+1
Joseph Fernandes

Syndicate lead · Austin, TX

99/100
$145K–$595KActive Sep 2026
AI & MLBiotech & PharmaCybersecurity+1
AI Pitch & Angel Matcher

Raising pre-seed or seed for your startup?

Don’t pitch blindly. Our AI engine evaluates your startup against Matthew Hellauer and 100+ active US & European angels to deliver 3 perfect matches with tailored warm intros and pitch deck reviews.